| Date | Title | Description |
| 28.06.2022 | Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic | The OncoSignature® test developed based on Acrivon’s AP3 platform is a first-of-its-kind spatial signature assay to identify patients most likely to respond to ACR-368, an advanced Phase 2 targeted oncology agent for solid cancers
The Onco... |
| 14.06.2022 | MOSAIC BIOSCIENCES SECURES FINANCING FROM TELEGRAPH HILL PARTNERS TO SUPPORT COMMERCIAL GROWTH AND EXPAND DRUG DISCOVERY CAPABILITIES AND SERVICES | Boulder, CO: Mosaic Biosciences (“Mosaic” or “the Company”), a protein and antibody discovery company that helps its partners identify next-generation therapies for the prevention and treatment of disease. announced the closing of a $11.4 m... |
| 17.05.2022 | Nimble Therapeutics Announces Achievement of Development Milestones from Multiple Partnered Programs Connected to a Strategic Large Pharma Collaboration | MADISON, WI, USA, [05/17/2022] — Nimble Therapeutics Inc. today announced the company has achieved the first development milestone for each of several programs attached to a multi-target collaboration with an undisclosed large pharma partne... |
| 13.04.2022 | bioMérieux strengthens its commitment to fight antimicrobial resistance with the acquisition of Specific Diagnostics, an innovative company focusing on fast AST solution | Marcy l’Étoile, France, April 12th 2022 – bioMérieux, a world leader in the field of in vitro diagnostics, announces that it has entered into an agreement to acquire Specific Diagnostics, a privately held U.S. based company that has develop... |
| 25.01.2022 | AmerisourceBergen and TrakCel Launch Integrated Platform to Support Cell and Gene Therapies | The integration of TrakCel’s OCELLOS and Lash Group’s Fusion aims to improve speed-to-therapy by increasing connectivity between providers and hub patient services
Conshohocken, Pa. (January 25, 2022) – AmerisourceBergen, a global healthca... |
| 25.01.2022 | Excellos Launches to Accelerate Innovation in the Cell and Gene Therapy Industry | Founded by an Experienced Management Team and Built on the Reach and Infrastructure of the San Diego Blood Bank
January 24, 2022 San Diego, CA: Excellos, Incorporated, a cell therapy Contract Development and Manufacturing Organization (C... |
| 05.01.2022 | Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution | MARLBOROUGH, Mass. and MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, and Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioacti... |
| 14.12.2021 | Carterra and PerkinElmer Sign Distribution Agreement For Asia-Pacific and Oceania Region for Carterra’s High Throughput Antibody Screening and Characterization Solutions | SALT LAKE CITY, UTAH (December 14, 2021) – Carterra, Inc. the world leader in label-free high throughput antibody screening and characterization, today announced that it has signed an exclusive Asia-Pacific and Oceania region distribution a... |
| 13.12.2021 | Akoya Biosciences Announces a Groundbreaking Collaboration with PathAI to Combine Spatial Biology with AI-Powered Tools to Facilitate Discovery of Novel Predictive Biomarkers | MARLBOROUGH, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, and PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, today announced a coll... |
| 15.11.2021 | Cell Microsystems Completes $10M Growth Financing | Funds will accelerate commercial activity and product development initiatives
Durham, NC: Cell Microsystems Inc, a developer and manufacturer of innovative products for single cell workflows, announced the closing of a $10 million financin... |
| 04.10.2021 | Specific Diagnostics Announces the First Purchase Orders in Europe | October 4, 2021 – Mountain View, California – FOR IMMEDIATE RELEASE
Specific Diagnostics today announced it has signed multi-year reagent rental agreements with two clinical microbiology laboratories in France, marking the commercializatio... |
| 14.09.2021 | Nimble Therapeutics and Incyte Expand their Strategic Research Collaboration to Discover Additional Novel Peptide Therapeutics | MADISON, WI, USA — Nimble Therapeutics, a biotechnology company revolutionizing the discovery and development of peptide therapeutics, today announced their strategic research collaboration with Incyte (NASDAQ: INCY) has been expanded to in... |
| 14.09.2021 | Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc. | LAKEWOOD, Colo., Sept. 14, 2021 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical quality control solutions for the pharmaceuti... |
| 08.09.2021 | Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis | MINNEAPOLIS and SALT LAKE CITY, Sept. 8, 2021 /PRNewswire/ — Bio-Techne, a leading supplier of high-quality and innovative tools for life science research, therapeutic manufacturing and clinical diagnostics and Carterra Inc., the world lead... |
| 29.06.2021 | Verogen and QIAGEN Partner to Deliver Innovative Solutions for Human Identification Laboratories | San Diego & HILDEN, Germany & GERMAN TOWN, Md – (BUSINESS WIRE) — QIAGEN N.V. (NYSE: QGEN) (Frankfurt Prime Standard: QIA) and Verogen today announced a partnership to provide laboratories with superior tools and comprehensive suppo... |
| 29.06.2021 | bioMérieux and Specific Diagnostics announce a co-exclusive distribution agreement for the SPECIFIC REVEAL® Rapid AST system in Europe | Marcy l’Étoile, France and Mountain View, California – June 29th, 2021 –
bioMérieux, a world leader in the field of in vitro diagnostics, and Specific
Diagnostics, a company bringing unique in vitro diagnostic systems to clinical
microbi... |
| 28.06.2021 | Nimble Therapeutics and RayzeBio Announce Strategic Research Collaboration to Discover & Develop Novel Peptide-Based Radiopharmaceuticals | Madison, WI, USA, & San Diego, CA, USA June 28, 2021 — Nimble Therapeutics and RayzeBio today announced the companies have entered a strategic collaboration to discover and develop novel peptide-based radiopharmaceuticals for treatment ... |
| 24.06.2021 | Teknova Announces Pricing of its Upsized Initial Public Offering | HOLLISTER, Calif., June 24, 2021 (GLOBE NEWSWIRE) — Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical products including drug therapies, novel vac... |
| 01.06.2021 | Precision NanoSystems joins Danaher’s Life Sciences Platform | PORT WASHINGTON, N.Y., June 1, 2021 /PRNewswire/ — Precision NanoSystems (PNI) has been acquired by Danaher Corporation’s Life Sciences platform. PNI is a global leader in technologies and solutions for the development of genetic medicines,... |
| 16.04.2021 | Akoya Biosciences Announces Pricing of Initial Public Offering | MARLBOROUGH, Mass., April 15, 2021 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the pricing of its initial public offering of 6,580,000 shares of its common stock at a pr... |
| 23.03.2021 | Akoya to Help Support the Human Cell Atlas (HCA) Initiative with Single-Cell, Spatial Imaging Capabilities | CODEX’s spatial phenotyping capabilities will contribute to HCA investigators’ ability to build comprehensive tissue maps.
MARLBOROUGH, Mass. — March 23, 2021 — Akoya Biosciences, Inc., The Spatial Biology Company®, today announced its sup... |
| 03.03.2021 | Bio-Techne to Acquire Asuragen | MINNEAPOLIS and AUSTIN, Texas, March 3, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today ... |
| 03.03.2021 | TrakCel Fuels Growth and Increased Market Access Through Strategic Investment Round | Cardiff, UK, March 3, 2021 ‒ TrakCel, a leading supplier of cellular orchestration solutions supporting the cell and gene therapy industry, today announces that it has closed its latest funding round led by AmerisourceBergen and Labcorp (NY... |
| 02.02.2021 | Precision NanoSystems Receives Contribution from the Government of Canada to Build RNA Medicine Biomanufacturing Centre | Vancouver BC. Precision NanoSystems, Inc. (PNI), a global leader in technologies and solutions for development of genetic medicines, announced today that it has received a contribution of CAD $25.1 million through the Strategic Innovation F... |
| 14.12.2020 | PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization | Carterra, Inc., the world leader in label-free high throughput antibody screening and characterization, today announced that they have closed on a round of equity financing led by PerkinElmer, Inc. Current Carterra investors Telegraph Hill ... |
| 02.12.2020 | Specific Diagnostics Announces Designation as an ISO-13485-Compliant Medical Device Manufacturer | December 2, 2020 – MOUNTAIN VIEW, California – FOR IMMEDIATE RELEASE
Specific Diagnostics today announced that it has received ISO-13485 certification through the International Organization for Standardization. A QMS conforming to ISO-1348... |
| 28.10.2020 | Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel | Agena Bioscience®, a global provider of low-cost and high-throughput molecular testing solutions, today announced that its MassARRAY® SARS-CoV-2 Panel for qualitative detection of the SARS-CoV-2 coronavirus has been granted Emergency Use Au... |
| 23.10.2020 | Precision NanoSystems Receives $18.2 Million from the Government of Canada to Develop an RNA Vaccine for COVID-19 | Vancouver BC. Precision Nanosystems, Inc. (PNI), a global leader in technologies and solutions in genetic medicine, announced today that it has received a commitment of up to $18.2 million in support from the Government of Canada under the ... |
| 05.10.2020 | Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based Therapeutics | Madison, WI, USA, October 5, 2020 — Nimble Therapeutics Inc. today announced the company has entered into a strategic collaboration with Incyte (NASDAQ: INCY) to discover first-in-class peptide therapies across various disease areas.
“This... |
| 25.09.2020 | Agena Bioscience Launches High-Throughput, Low-Cost SARS-CoV-2 Detection Panel in Europe with CE-IVD Marking | San Diego, CA – Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, today announced that it has obtained CE-IVD marking for its SARS-CoV-2 Panel, an in vitro diagnostic test for the qualitative d... |
| 17.08.2020 | A New SARS-CoV-2 Spike Protein Biosensor Chip was Successfully Deployed for Simultaneous Measurements of IgG, IgA, and IgM Using Only 2 µL of Serum per Patient | Salt Lake City, Utah. Carterra® Inc., the world leader in high-throughput antibody screening and characterization, has announced the availability of a highly accurate assay for simultaneously measuring the concentration and binding of IgG, ... |
| 29.07.2020 | Akoya Biosciences Collaborates with Leading Cancer Center to Discover Predictive Biomarkers for Cancer | At UCSF, this collaboration will be led by Michael Campbell, PhD, and Laura Esserman, MD, MBA. Dr. Campbell is an immunologist who has worked in partnership with Dr. Esserman to better understand how to optimize immunotherapy. He is driving... |
| 21.07.2020 | Argonaut Manufacturing Services Expands Capacity for COVID-19 Viral Transport Media (VTM) Filling | CARLSBAD, CA – Argonaut Manufacturing Services, a contract manufacturing organization (CMO) serving the life sciences, molecular diagnostics, and biopharma industries, announced today that they have completed an expansion of their Viral Tra... |
| 07.07.2020 | Asuragen Announces CE Mark of AmplideX® SMA Plus Kit | The assay is intended to aid in the diagnosis of and identification of carriers for spinal muscular atrophy (SMA)
AUSTIN, Texas–(BUSINESS WIRE)– Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex te... |
| 02.07.2020 | Magstim Acquires Electrical Geodesics, Inc. (EGI) Product Portfolio | High-density EEG complements Magstim’s Transcranial Magnetic Stimulation Technology Driving Innovation
MINNEAPOLIS, Minn. & Carmarthenshire, UK — (July 2, 2020) – Magstim, the global leader in Transcranial Magnetic Stimulation (TMS), t... |
| 17.06.2020 | Sirnaomics and Precision NanoSystems Have Formed a Partnership Developing and Manufacturing Novel RNAi Drug Candidates Using Precision NanoSystems’ NxGen™ Platform | Gaithersburg, MD, and Vancouver, Canada – Sirnaomics Inc. (Sirnaomics) and Precision NanoSystems Inc. (PNI) jointly announced a partnership on the development and manufacture of the polypeptide nanoparticle-based RNAi therapeutic product. T... |
| 16.06.2020 | Agena Bioscience Announces EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel | Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, today announced the launch of the iPLEX® Pro SARS-CoV-2 Panel for qualitative detection of the novel coronavirus that causes COVID-19. Clinical... |
| 02.06.2020 | Specific Diagnostics Announces that NIAID has Awarded the Company a Further $2.9 million for the Commercial Development of the Reveal Rapid Antibiotic Susceptibility Testing (AST) System | MOUNTAIN VIEW, California, June 2, 2020 – Specific Diagnostics today announces that the National Institute for Allergy and Infectious Disease (NIAID) has awarded a second major grant to drive the commercial introduction of Specific’s Reveal... |
| 20.05.2020 | CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine | – CanSinoBIO will license in Precision NanoSystems’ proprietary RNA vaccine platform technology
– Precision NanoSystems will lead RNA vaccine formulation development
– CanSinoBIO will lead COVID-19 antigen design, pre-clinical testing and... |
| 19.05.2020 | Nivagen Pharmaceuticals Closes $16 Million Growth Equity Financing from Telegraph Hill Partners | Additional Resources Will Support Product Development and Expansion of Manufacturing Capabilities
Sacramento, Calif.—(May 19, 2020)—Nivagen Pharmaceuticals, Inc. (“Nivagen”), a specialty pharmaceuticals company, announced the closing of ... |
| 06.05.2020 | Nimble announces collaboration to discover and develop novel peptide-based compounds for SARS-CoV-2 diagnostics | MADISON, WI–Nimble Therapeutics, Inc. today announced a collaboration with Roche Diagnostics to accelerate discovery of novel peptide-based molecules for the development of SARS-CoV-2 in vitro diagnostic assays.
Nimble will extend its prop... |
| 16.04.2020 | Nimble & Svar Life Science Announce Collaboration to Discover, Develop and Commercialize Diagnostic Tests based on Nimble’s Novel Biomarker Discovery Engine | MADISON, WI, USA and Malmö, SE — Nimble Therapeutics and Svar Life Science today announced a collaboration to discover, develop, and commercialize diagnostic tests based on Nimble’s powerful and broadly applicable biomarker discovery engine... |
| 08.04.2020 | Precision NanoSystems Appoints Dr. Andrew Geall as Chief Scientific Officer | Vancouver BC, April 8, 2020 Precision NanoSystems (PNI), a global leader in enabling transformative nanomedicines today announced the appointment of Dr. Andrew Geall as the company’s Chief Scientific Officer (CSO). Dr. Geall has over 20 yea... |
| 01.04.2020 | Carterra® Inc. Selected by the La Jolla Institute of Immunology to Provide Antibody Screening and Characterization for the Coronavirus Immunotherapy Consortium (CoVIC) | Salt Lake City, Utah and La Jolla, California, USA. Carterra® Inc., the world leader in high-throughput antibody screening and characterization tools, and La Jolla Institute for Immunology (LJI), announced today that they will use Carterra’... |
| 27.03.2020 | Dynex® Technologies Assisting in the Fight Against COVID-19 | Dynex’s portfolio of open, automated microplate instruments, with a global distribution network and footprint, demonstrates ability to support COVID-19 testing worldwide.
CHANTILLY, VA March 27, 2020 – Dynex Technologies, Inc., announced t... |
| 19.12.2019 | RareCyte Closes $22M Financing for Global Commercialization and Platform Expansion into Tissue Multiplexing | SEATTLE, Dec. 19, 2019 /PRNewswire/ — RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company creating liquid and tissue biopsy analysis platforms with emphasis on rare cell detection announced today the completion of a $22M fi... |
| 09.12.2019 | GEDmatch Partners with Genomics Firm | SAN DIEGO, CA (December 9, 2019) — GEDmatch, a pioneer in consumer genealogy, today announced that it has joined with forensic genomics firm Verogen, Inc. in a move that allows the company to ensure ongoing privacy protections and enhance t... |
| 05.12.2019 | Akoya Biosciences Raises $50M in Financing | Additional Resources Will Support Continued Commercialization of Akoya’s Spatial Biology Platforms CODEX® and Phenoptics™
Company to present at Piper Jaffray 31st Annual Healthcare Conference
Akoya Biosciences, Inc., The Spatial Biology C... |
| 05.11.2019 | Argonaut Manufacturing Services Announces Addition to Board of Directors | Carlsbad, CA, Nov 05, 2019 – Argonaut Manufacturing Services announced today that Mark O’Donnell has been appointed to the company’s Board of Directors. Mr. O’Donnell joins the Argonaut Board with over 40 years of experience in global opera... |
| 29.10.2019 | Premier Inc. Acquires Medpricer to Optimize Savings in Purchase Services | - |
| 08.10.2019 | Precision NanoSystems to Launch the Revolutionary Ignite™ | - |
| 05.09.2019 | Bristol-Myers Squibb, Boehringer Ingelheim and Other Biotechnology Companies to Present Use of Carterra’s Next Generation Antibody Screening Technology at Symposia Across the US and Europe | Salt Lake City, Utah, USA. Carterra® Inc., the world leader in high-throughput antibody screening and characterization, will host a series of symposia across the United States and Europe entitled, The therapeutic antibody revolution in the ... |
| 07.08.2019 | Centerstone employs InvisAlert’s technology for patient monitoring | Bradenton, Fla .—Centerstone, a national leader in behavioral health care, has started using new and highly-effective patient safety technology for patients in its care on the Brandon campus. Centerstone is the first healthcare organization... |
| 18.07.2019 | Study Shows Spatial Biology Is Essential for Predicting Response to Immuno-Oncology Treatment | MENLO PARK, CA — July 18, 2019 — Akoya Biosciences, Inc., The Spatial Biology Company™, announced today that an in-depth comparison of immuno-oncology biomarker types conducted by scientists at Johns Hopkins University, Yale University, and... |
| 04.06.2019 | First Criminal Conviction Secured with Next-Gen Forensic DNA Technology | San Diego, June 4, 2019—Verogen announced today that its DNA sequencing technology played a pivotal role in a recent court case in the Netherlands. This marks the first time that evidence generated with so-called “next generation” or massiv... |
| 31.10.2018 | Akoya Biosciences Acquires Quantitative Pathology Solutions Portfolio from PerkinElmer | MENLO PARK–(BUSINESS WIRE)—October 31, 2018—Akoya Biosciences (Akoya), a Telegraph Hill Partners (THP) company, has acquired PerkinElmer, Inc’s Quantitative Pathology Solutions (QPS) portfolio. Akoya was founded in 2015 to commercialize the... |
| 24.10.2018 | AGENA AND DARUI BIOTECHNOLOGY ANNOUNCE CHINA FDA CLEARANCE OF MASSARRAY TECHNOLOGY FOR DIAGNOSTIC USE IN CHINA | SAN DIEGO, Calif., and GUANGZHOU, China, Wednesday, October 24, 2018 – Agena Bioscience (Agena) and DaRui Biotechnology (DaRui) announced today that the MassARRAY System has formally passed the registration application of Guangdong Food and... |
| 05.09.2018 | Asuragen Expands Oncology Portfolio with CE Marking and Launch of QuantideX® NGS DNA Hotspot 21 Kit | The panel accurately and sensitively detects over 1600 variants of clinical significance
AUSTIN, Texas — Asuragen, Inc., a molecular diagnostics company delivering high-quality, easy to use products for complex testing in genetics and onco... |
| 11.07.2018 | Argonaut Manufacturing Services acquires lyophilization expert LyoGen | Carlsbad, CA, 07/11/18– Argonaut Manufacturing Services, a contract development and manufacturing organization (CDMO) serving molecular diagnostic and biopharmaceutical companies, today announced it has reached a definitive agreement to acq... |
| 26.04.2018 | LakePharma Expands Service Capability with Purchase of Carterra™ High Throughput Antibody Characterization LSA™ Instrumentation | First Contract Development & Manufacturing Organization to Install Carterra’s Next Generation Label-Free Biosensor to Support Antibody Discovery Services Business
Salt Lake City, UT, USA and South San Francisco, CA, USA, April 26th 201... |
| 16.04.2018 | RareCyte introduces the CyteFinder® HT instrument at AACR for high throughput slide-based imaging optimized for single cell Liquid Biopsy | Seattle, WA, April 16, 2018 – RareCyte, Inc., a global rare cell detection and liquid biopsy company announces its newest product, CyteFinder HT in conjunction with the American Association for Cancer Research (AACR) Annual Meeting in Chica... |
| 26.03.2018 | AGENA AND SIMCEREDX ANNOUNCE STRATEGIC PARTNERSHIP TO DEVELOP AND COMMERCIALIZE COMPANION DIAGNOSTICS IN CHINA | SAN DIEGO, Calif., and NANJING, JiangSu, March 26, 2018 – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the subsidiary of SIMCERE Pharmaceutical Group, announced today the signing of a strategic partnership agreement focusin... |
| 13.03.2018 | Carterra™ Announces Multiple Sales of its New LSA™ Array SPR Instrument for Comprehensive Monoclonal Antibody Characterization | Salt Lake City, Utah, USA… Carterra Inc., an innovative label-free biosensor company, announced today that it has sold multiple units of its new, fully integrated, high throughput monoclonal antibody (mAb) screening and characterization ins... |
| 17.01.2018 | Carterra Inc. Raises $10M from Telegraph Hill Partners to Develop and Launch Next-Generation Antibody Characterization Platform | Additional Resources Will Drive Commercialization of Novel High-Throughput Label-Free Biosensor for Streamlined Antibody Characterization
Salt Lake City, Utah, USA…Carterra Inc., an innovative label-free biosensor company, has announced ... |
| 17.01.2018 | Asuragen Obtains CE Mark of QuantideX® qPCR BCR-ABL Kits on Roche Diagnostics cobas z 480 Analyzer | AUSTIN, Texas– Asuragen, Inc., a global molecular diagnostics product company changing the way patients are treated in genetics and oncology by bringing complex molecular tests to hospital and reference labs, today announced that it has exp... |
| 24.10.2017 | AQUARO HISTOLOGY COMPLETES FINANCING TO SUPPORT COMMERCIALIZATION OF AUTOMATED MICROTOMY TECHNOLOGY | October 24, 2017
Ann Arbor, MI: Aquaro Histology, Inc. (formerly known as Aquaro Biosystems, LLC) announced today the completion of a Series A funding round of $9.8 million led by Telegraph Hill Partners. This investment will enable Aquaro... |
| 27.09.2017 | HIGHLY SENSITIVE ASSESSMENT OF COMMON SOMATIC MUTATIONS IN PULMONARY NON-SMALL CELL CARCINOMA WITH THE MASSARRAY® SYSTEM | San Diego, CA, September 27, 2017 – Agena Bioscience today announced a comparative study published in PLOS ONE highlighting the use of its mass spectrometry-based platform and new, highly sensitive iPLEX® HS chemistry for detection of somat... |
| 11.09.2017 | Iovance Biotherapeutics Partners with TrakCel for Personalized Patient Product Management | TrakCel Solution will electronically link Iovance with clinical sites, contract manufacturing organizations and couriers to schedule and track TIL therapies for each patient
SAN CARLOS, Calif., Sept. 11, 2017 (GLOBE NEWSWIRE) — Iovance Bio... |
| 07.09.2017 | TrakCel announces a partnership agreement to incorporate its needle-to-needle supply chain management platform into the CGT Catapult’s large-scale cell and gene therapy manufacturing centre | TrakCel solution integration with Cell and Gene Therapy Catapult manufacturing centre enables needle-to-needle supply chain management at any scale
London, UK, September 7, 2017 – TrakCel today announced a partnership agreement to incorpor... |
| 29.08.2017 | RareCyte Completes $30M Private Financing for Commercial Expansion of Rare Cell Detection Technology for Liquid Biopsies | Seattle, WA, August 24, 2017 – RareCyte, Inc., a global rare cell detection and liquid biopsy company will use the funding to advance its commercial sales efforts and build companion diagnostics (CDx) programs with strategic partners. The C... |
| 24.08.2017 | Illumina and Telegraph Hill Partners Launch Verogen, Inc. to Drive Adoption of Next-Generation Sequencing in the Global Forensic Genomics Market | San Diego–(BUSINESS WIRE)—August 24, 2017– Illumina Inc. (NASDAQ: ILMN) today announced plans with Telegraph Hill Partners (THP), a San Francisco-based venture capital and growth equity firm, to establish Verogen, Inc. The independent new c... |
| 02.08.2017 | Asuragen Expands QuantideX® qPCR BCR-ABL Portfolio for Monitoring Molecular Response in Chronic Myeloid Leukemia | AUSTIN, Texas–(BUSINESS WIRE)– Asuragen, Inc., a molecular diagnostics company changing the way diagnostics impact patient care in genetics and oncology, announced today the availability of their CE-marked QuantideX® qPCR BCR-ABL minor Kit*... |
| 02.08.2017 | Agena MassARRAY® System Selected for Illinois State Cystic Fibrosis Screening of Newborns | San Diego, CA, August 2, 2017– Agena Bioscience has entered into a 3-year agreement with the Illinois Department of Public Health (IDPH) which will deploy Agena’s MassARRAY System for Cystic Fibrosis (CF) testing as part of the state’s newb... |
| 29.06.2017 | MassARRAY® System with Chip Prep Module receives CE-IVD marking for general in vitro diagnostic use in Europe | SAN DIEGO, Calif., June 29, 2017– Agena Bioscience today announced the European launch of the MassARRAY® System with CHIP Prep Module (CPM), marketed as a CE-IVD product under the Directive 98/79/EC for in vitro diagnostic medical devices.
... |
| 20.06.2017 | Agena Bioscience Announces Expanded Partnership With Assurex Health | MassARRAY® System Selected for Assurex Health’s GeneSight Test
SAN DIEGO, Calif., June 20, 2017– Agena Bioscience today announced that Assurex Heath, a wholly owned subsidiary of Myriad Genetics, Inc., has selected the MassARRAY® System fo... |
| 15.10.2016 | THP invests in leading Cellular Orchestration Platform developer, TrakCel | CARDIFF, WALES, UK – TrakCel, the leading provider of cellular orchestration technology to aid in the delivery of regenerative therapies, has successfully completed a multi-million dollar investment by San Francisco-based Telegraph Hill Par... |
| 10.10.2015 | THP Invests in Precision NanoSystems | Precision NanoSystems, Inc. (PNI), a global nanomedicine company, has announced the completion of a $13.4 million private Series A financing. The investment was led by 5AM Ventures and Telegraph Hill Partners, with additional participants t... |
| 15.08.2015 | Nitinol Devices & Components Acquires Interface Catheter Solutions to Create Confluent Medical Technologies | FREMONT, Calif.– (BUSINESS WIRE)–Nitinol Devices & Components, Inc. (“NDC”), announced today it has successfully completed the acquisition of Interface Catheter Solutions (“Interface”). Reflecting the combination’s expanded strategic br... |
| 31.12.2014 | PneumRx Acquired by BTG for up to $475 Million | Mountain View, CA—December 4, 2014—/PRNewswire/—PneumRx, Inc. (www.pneumrx.com), a leader in the field of interventional pulmonology, today announced that it has signed an agreement to be acquired by BTG Plc (LSE:BTG) in a deal worth up to ... |
| 31.08.2014 | Horizon Discovery Group plc Acquires Sage Labs Inc. for $48M (£29M) | Acquisition makes Horizon the world’s leading gene-editing and translational genomics company
Cambridge, UK and St. Louis, MO, USA—September 29, 2014—Horizon Discovery Group plc (LSE: HZD) (“Horizon” or the “Company”), the international li... |
| 31.07.2014 | AngioScore acquired by The Spectranetics Corporation | Colorado Springs, Colo., June 30, 2014 (GLOBE NEWSWIRE)—The Spectranetics Corporation (Nasdaq:SPNC) today announced that it has completed the acquisition of AngioScore Inc., a leading developer, manufacturer and marketer of cardiovascular, ... |
| 31.05.2014 | Sequenom, Inc.’s Bioscience Business Acquired by Agena Bioscience, a Telegraph Hill Partners Portfolio Company | John Lillig to Lead Agena Bioscience as Chairman and Interim CEO
San Diego, Calif., May 30, 2014—Agena Bioscience, Inc., a portfolio company of Telegraph Hill Partners (THP), today acquired the Bioscience business of Sequenom, Inc. (NASDAQ... |
| 01.02.2014 | Telegraph Hill Partners Announces Appointment of Paul D. Grossman as Venture Partner | Former Life Technologies’ Head of Strategy & Corporate Development Expands Firm’s Technology, Business Strategy and Operating Expertise
San Francisco, February 10, 2014—Telegraph Hill Partners (THP), a leading venture capital and growt... |
| 31.01.2014 | AtriCure Completes Acquisition of Estech | WEST CHESTER, Ohio—(BUSINESS WIRE)—Jan. 2, 2014—AtriCure, Inc. (Nasdaq: ATRC), a leading Atrial Fibrillation medical device provider, today announced the completion of the previously announced acquisition of Endoscopic Technologies, Inc. d/... |
| 31.10.2013 | LDR Prices Initial Public Offering | AUSTIN, Texas, Oct. 8, 2013 (GLOBE NEWSWIRE) – LDR Holding Corporation (Nasdaq:LDRH) (“LDR” or the “Company”), a global medical device company focused on designing and commercializing novel and proprietary spinal surgical technologies, toda... |
| 31.10.2013 | Vidacare Corporation to be acquired by Teleflex | Vidacare Corporation to be acquired by TeleflexVidacare Corporation of San Antonio, Texas has entered into a merger agreement
to be acquired by Teleflex Incorporated.
San Antonio, Texas, October 29, 2013 – Medical device manufacturer Vida... |
| 31.07.2013 | Telegraph Hill Partners Raises $310M Fund for New Investments In Life Science and Healthcare Companies | San Francisco, July 29, 2013 – Telegraph Hill Partners (THP), a leading venture capital and growth equity firm dedicated exclusively to life science and healthcare investing, has had its final closing on a new $310 million fund and plans to... |
| 31.03.2013 | Althea Technologies, Inc. Acquired by Ajinomoto Co., Inc. | Acquisition Expected to Give Ajinomoto Co., Inc. Entry Into the Contract Development and Manufacturing Market
San Diego, Calif., March 6, 2013—Ajinomoto Co., Inc. (“Ajinomoto Co.”; TYO: 2802) and Althea Technologies, Inc. (“Althea Technolo... |
